As of 2025-09-15, the Relative Valuation of Anika Therapeutics Inc (ANIK) is (54.87) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.67 USD, the upside of Anika Therapeutics Inc based on Relative Valuation is -732.8%.
The range of the Relative Valuation is (45.74) - (60.21) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.0x - 14.3x | 12.5x |
| Forward P/E multiples | 10.9x - 17.2x | 13.6x |
| Fair Price | (45.74) - (60.21) | (54.87) |
| Upside | -627.6% - -794.4% | -732.8% |
| Date | P/E |
| 2025-09-12 | -2.06 |
| 2025-09-11 | -2.05 |
| 2025-09-10 | -2.00 |
| 2025-09-09 | -2.08 |
| 2025-09-08 | -2.13 |
| 2025-09-05 | -2.13 |
| 2025-09-04 | -2.16 |
| 2025-09-03 | -2.14 |
| 2025-09-02 | -2.18 |
| 2025-08-29 | -2.23 |
| 2025-08-28 | -2.20 |
| 2025-08-27 | -2.18 |
| 2025-08-26 | -2.22 |
| 2025-08-25 | -2.17 |
| 2025-08-22 | -2.30 |
| 2025-08-21 | -2.15 |
| 2025-08-20 | -1.99 |
| 2025-08-19 | -2.04 |
| 2025-08-18 | -2.07 |
| 2025-08-15 | -2.10 |
| 2025-08-14 | -2.06 |
| 2025-08-13 | -2.16 |
| 2025-08-12 | -2.07 |
| 2025-08-11 | -1.95 |
| 2025-08-08 | -1.93 |
| 2025-08-07 | -1.96 |
| 2025-08-06 | -1.96 |
| 2025-08-05 | -1.99 |
| 2025-08-04 | -2.09 |
| 2025-08-01 | -2.06 |
| 2025-07-31 | -1.96 |
| 2025-07-30 | -1.93 |
| 2025-07-29 | -2.65 |
| 2025-07-28 | -2.69 |
| 2025-07-25 | -2.74 |
| 2025-07-24 | -2.69 |
| 2025-07-23 | -2.74 |
| 2025-07-22 | -2.62 |
| 2025-07-21 | -2.54 |
| 2025-07-18 | -2.50 |
| 2025-07-17 | -2.67 |
| 2025-07-16 | -2.66 |
| 2025-07-15 | -2.62 |
| 2025-07-14 | -2.74 |
| 2025-07-11 | -2.68 |
| 2025-07-10 | -2.80 |
| 2025-07-09 | -2.65 |
| 2025-07-08 | -2.61 |
| 2025-07-07 | -2.57 |
| 2025-07-03 | -2.68 |